In the US, Ceftazidime (ceftazidime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bacteremia, Bladder Infection, Bone infection, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Joint Infection, Kidney Infections, Melioidosis, Meningitis, Nosocomial Pneumonia, Otitis Externa, Otitis Media, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Sepsis, Septicemia, Sinusitis, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.
US matches:
- Ceftazidime
- Ceftazidime injection
UK matches:
- Ceftazidime 1g Powder for solution for injection (SPC)
- Ceftazidime 2g Powder for solution for injection or infusion (Wockhardt UK Ltd) (SPC)
Ingredient matches for Ceftazidime
Ceftazidime (BAN, DCF, JAN, USAN) is known as Ceftazidime in the US.
Cefotaxime is reported as an ingredient of Ceftazidime in the following countries:
- Russian Federation
Cefprozil is reported as an ingredient of Ceftazidime in the following countries:
- United States
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| JAN | Japanese Accepted Name |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment